234
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL

ORCID Icon, , , , , , & ORCID Icon show all
Pages 2306-2315 | Received 12 Jun 2023, Accepted 07 Sep 2023, Published online: 21 Sep 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.